Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03272217
Title Atezolizumab With or Without Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Arjun Balar, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona at Dignity Health St. Joseph Phoenix Arizona 85004 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
HealthPartners Institute Minneapolis Minnesota 55440 United States Details
New York University Clinical Cancer Center New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
West Cancer Center University of Tennessee Memphis Tennessee 38120 United States Details
Froedtert & The Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field